Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trialTina Cascone, Boris Sepesi|Nature Medicine|2023Cited by 202
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective studyMaliazurina B. Saad, Jia Wu, Xuetao Lu et al.|The Lancet Digital Health|2023Cited by 108
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Boris Sepesi|Nature Communications|2021Cited by 105
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma DevelopmentWarapen Treekitkarnmongkol, Humam Kadara, Maya Hassane et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 46